Market Cap (In GBp)
172.24 Million
Revenue (In GBp)
13.6 Million
Net Income (In GBp)
8.09 Million
Avg. Volume
3930.00
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2977.0-5100.0
- PE
- -
- EPS
- -
- Beta Value
- 0.39
- ISIN
- GB00B4QVDF07
- CUSIP
- G1285U100
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Peter John Harrison MA
- Employee Count
- -
- Website
- https://www.bioventix.com
- Ipo Date
- 2014-04-29
- Details
- Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.
More Stocks
-
DWAYDriveItAway Inc.
DWAY
-
AMSLFAustralian Mines Limited
AMSLF
-
2506
-
PSTL
-
SLNFFSolution Financial Inc.
SLNFF
-
V6CViscom AG
V6C
-
WLDSWWearable Devices Ltd.
WLDSW
-
GWMO